[Digoxin toxicity secondary to inhibition of digoxin intestinal metabolism in a patient receiving clarithromycin].
Vergara-López
Salvador
S
García-García
José A
JA
Merchante
Nicolás
N
Mira
José Antonio
JA
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D017291:Clarithromycin / Q000009:adverse effects*; D004077:Digoxin / Q000494:pharmacology*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005260:Female; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002316:Cardiotonic Agents; D004077:Digoxin; D017291:Clarithromycin